Detalhe da pesquisa
1.
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.
Mol Ther
; 31(8): 2342-2359, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312451
2.
Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.
Int J Mol Sci
; 22(5)2021 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33652578
3.
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy.
Cancer Immunol Immunother
; 68(11): 1839-1853, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31222484
4.
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.
Cancer Immunol Immunother
; 68(1): 131-141, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29947961
5.
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance.
Curr Top Microbiol Immunol
; 405: 99-122, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294003
6.
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.
Int J Mol Sci
; 19(3)2018 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29534457
7.
CSPG4: a prototype oncoantigen for translational immunotherapy studies.
J Transl Med
; 15(1): 151, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28668095
8.
The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2(+) mammary cancer.
Plant Biotechnol J
; 14(1): 153-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25865255
9.
The importance of comparative oncology in translational medicine.
Cancer Immunol Immunother
; 64(2): 137-48, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25548094
10.
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
BMC Genomics
; 15 Suppl 3: S1, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077564
11.
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.
Am J Pathol
; 182(6): 2058-70, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623609
12.
A single cell RNAseq benchmark experiment embedding "controlled" cancer heterogeneity.
Sci Data
; 11(1): 159, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307867
13.
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research.
Front Vet Sci
; 9: 803093, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224082
14.
Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy.
Cells
; 11(1)2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35011736
15.
Improving Osteosarcoma Treatment: Comparative Oncology in Action.
Life (Basel)
; 12(12)2022 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556464
16.
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Oncoimmunology
; 11(1): 2086752, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35756841
17.
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020).
Vet Comp Oncol
; 20(1): 189-197, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392602
18.
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580930
19.
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis.
Biomedicines
; 10(2)2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203439
20.
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer.
Cancers (Basel)
; 14(16)2022 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36011047